Cargando…

The Anti-Inflammatory Effect of a Combination of Five Compounds From Five Chinese Herbal Medicines Used in the Treatment of COPD

Effective compound combination (ECC; i.e, 20-S-ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol), derived from Chinese herbal medicine, significantly ameliorates chronic obstructive pulmonary disease (COPD) in rats; however, the underlying mechanisms of ECC remain largely unclear. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jiansheng, Zhao, Peng, Tian, Yange, Li, Kangchen, Zhang, Lanxi, Guan, Qingzhou, Mei, Xiaofeng, Qin, Yanqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578279/
https://www.ncbi.nlm.nih.gov/pubmed/34776947
http://dx.doi.org/10.3389/fphar.2021.709702
_version_ 1784596230617169920
author Li, Jiansheng
Zhao, Peng
Tian, Yange
Li, Kangchen
Zhang, Lanxi
Guan, Qingzhou
Mei, Xiaofeng
Qin, Yanqin
author_facet Li, Jiansheng
Zhao, Peng
Tian, Yange
Li, Kangchen
Zhang, Lanxi
Guan, Qingzhou
Mei, Xiaofeng
Qin, Yanqin
author_sort Li, Jiansheng
collection PubMed
description Effective compound combination (ECC; i.e, 20-S-ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol), derived from Chinese herbal medicine, significantly ameliorates chronic obstructive pulmonary disease (COPD) in rats; however, the underlying mechanisms of ECC remain largely unclear. In this study, network pharmacology analysis integrated with experimental validation was used to explore the therapeutic mechanisms of ECC against COPD. ECC targets and COPD genes and targets were identified from multiple databases, and then used for an analysis of protein–protein interaction (PPI) networks, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, and biological functioning. BisoGenet was used to comprehensively analyze the hub-network. We validated the therapeutic effect and mechanisms of ECC both in vivo and in vitro. We identified 45 ECC targets, which were mainly related to inflammatory processes, such as the NOD-like and NF-kappa B signaling pathways, hematopoietic cell lineage, Th17 cell differentiation, cellular response to lipopolysaccharide, and interleukin-8 secretion. In addition, 1180 COPD genes and 70 COPD targets were identified as being involved in the biological functions associated with COPD development, such as cytokine–cytokine receptor interaction, the TNF signaling pathway, the mitogen-activated protein kinase (MAPK) signaling pathway, regulation of lymphocyte proliferation, and positive regulation of leukocyte migration. Integrative analysis of COPD genes and targets and ECC target networks revealed that 54 genes were mainly involved in the inflammatory process, such as IL-17 signaling, NF-kappa B signaling, innate immune response–activating signal transduction, and macrophage cell differentiation. Six targets (AR, ESR1, HNRNPA1, PAPR1, TP53, and VCAM1) contained in the hub-network and their four related compounds were obtained and recognized as the key molecules associated with the effects of ECC. Molecular docking validation demonstrated that four compounds could bind to six targets that interact with COPD genes. Finally, in vivo and in vitro experiments verified that ECC treatment ameliorated the symptoms of COPD in rats by improving their lung function, reducing pathological changes, and suppressing oxidative responses and pro-inflammatory cytokine secretion, while inhibiting inflammation in LPS-induced macrophages, which may be associated with NF-kappa B and MAPK signaling regulation. This study demonstrates the therapeutic mechanisms and effects of ECC on COPD via regulation of the underlying inflammatory process.
format Online
Article
Text
id pubmed-8578279
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85782792021-11-11 The Anti-Inflammatory Effect of a Combination of Five Compounds From Five Chinese Herbal Medicines Used in the Treatment of COPD Li, Jiansheng Zhao, Peng Tian, Yange Li, Kangchen Zhang, Lanxi Guan, Qingzhou Mei, Xiaofeng Qin, Yanqin Front Pharmacol Pharmacology Effective compound combination (ECC; i.e, 20-S-ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol), derived from Chinese herbal medicine, significantly ameliorates chronic obstructive pulmonary disease (COPD) in rats; however, the underlying mechanisms of ECC remain largely unclear. In this study, network pharmacology analysis integrated with experimental validation was used to explore the therapeutic mechanisms of ECC against COPD. ECC targets and COPD genes and targets were identified from multiple databases, and then used for an analysis of protein–protein interaction (PPI) networks, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, and biological functioning. BisoGenet was used to comprehensively analyze the hub-network. We validated the therapeutic effect and mechanisms of ECC both in vivo and in vitro. We identified 45 ECC targets, which were mainly related to inflammatory processes, such as the NOD-like and NF-kappa B signaling pathways, hematopoietic cell lineage, Th17 cell differentiation, cellular response to lipopolysaccharide, and interleukin-8 secretion. In addition, 1180 COPD genes and 70 COPD targets were identified as being involved in the biological functions associated with COPD development, such as cytokine–cytokine receptor interaction, the TNF signaling pathway, the mitogen-activated protein kinase (MAPK) signaling pathway, regulation of lymphocyte proliferation, and positive regulation of leukocyte migration. Integrative analysis of COPD genes and targets and ECC target networks revealed that 54 genes were mainly involved in the inflammatory process, such as IL-17 signaling, NF-kappa B signaling, innate immune response–activating signal transduction, and macrophage cell differentiation. Six targets (AR, ESR1, HNRNPA1, PAPR1, TP53, and VCAM1) contained in the hub-network and their four related compounds were obtained and recognized as the key molecules associated with the effects of ECC. Molecular docking validation demonstrated that four compounds could bind to six targets that interact with COPD genes. Finally, in vivo and in vitro experiments verified that ECC treatment ameliorated the symptoms of COPD in rats by improving their lung function, reducing pathological changes, and suppressing oxidative responses and pro-inflammatory cytokine secretion, while inhibiting inflammation in LPS-induced macrophages, which may be associated with NF-kappa B and MAPK signaling regulation. This study demonstrates the therapeutic mechanisms and effects of ECC on COPD via regulation of the underlying inflammatory process. Frontiers Media S.A. 2021-10-27 /pmc/articles/PMC8578279/ /pubmed/34776947 http://dx.doi.org/10.3389/fphar.2021.709702 Text en Copyright © 2021 Li, Zhao, Tian, Li, Zhang, Guan, Mei and Qin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Li, Jiansheng
Zhao, Peng
Tian, Yange
Li, Kangchen
Zhang, Lanxi
Guan, Qingzhou
Mei, Xiaofeng
Qin, Yanqin
The Anti-Inflammatory Effect of a Combination of Five Compounds From Five Chinese Herbal Medicines Used in the Treatment of COPD
title The Anti-Inflammatory Effect of a Combination of Five Compounds From Five Chinese Herbal Medicines Used in the Treatment of COPD
title_full The Anti-Inflammatory Effect of a Combination of Five Compounds From Five Chinese Herbal Medicines Used in the Treatment of COPD
title_fullStr The Anti-Inflammatory Effect of a Combination of Five Compounds From Five Chinese Herbal Medicines Used in the Treatment of COPD
title_full_unstemmed The Anti-Inflammatory Effect of a Combination of Five Compounds From Five Chinese Herbal Medicines Used in the Treatment of COPD
title_short The Anti-Inflammatory Effect of a Combination of Five Compounds From Five Chinese Herbal Medicines Used in the Treatment of COPD
title_sort anti-inflammatory effect of a combination of five compounds from five chinese herbal medicines used in the treatment of copd
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578279/
https://www.ncbi.nlm.nih.gov/pubmed/34776947
http://dx.doi.org/10.3389/fphar.2021.709702
work_keys_str_mv AT lijiansheng theantiinflammatoryeffectofacombinationoffivecompoundsfromfivechineseherbalmedicinesusedinthetreatmentofcopd
AT zhaopeng theantiinflammatoryeffectofacombinationoffivecompoundsfromfivechineseherbalmedicinesusedinthetreatmentofcopd
AT tianyange theantiinflammatoryeffectofacombinationoffivecompoundsfromfivechineseherbalmedicinesusedinthetreatmentofcopd
AT likangchen theantiinflammatoryeffectofacombinationoffivecompoundsfromfivechineseherbalmedicinesusedinthetreatmentofcopd
AT zhanglanxi theantiinflammatoryeffectofacombinationoffivecompoundsfromfivechineseherbalmedicinesusedinthetreatmentofcopd
AT guanqingzhou theantiinflammatoryeffectofacombinationoffivecompoundsfromfivechineseherbalmedicinesusedinthetreatmentofcopd
AT meixiaofeng theantiinflammatoryeffectofacombinationoffivecompoundsfromfivechineseherbalmedicinesusedinthetreatmentofcopd
AT qinyanqin theantiinflammatoryeffectofacombinationoffivecompoundsfromfivechineseherbalmedicinesusedinthetreatmentofcopd
AT lijiansheng antiinflammatoryeffectofacombinationoffivecompoundsfromfivechineseherbalmedicinesusedinthetreatmentofcopd
AT zhaopeng antiinflammatoryeffectofacombinationoffivecompoundsfromfivechineseherbalmedicinesusedinthetreatmentofcopd
AT tianyange antiinflammatoryeffectofacombinationoffivecompoundsfromfivechineseherbalmedicinesusedinthetreatmentofcopd
AT likangchen antiinflammatoryeffectofacombinationoffivecompoundsfromfivechineseherbalmedicinesusedinthetreatmentofcopd
AT zhanglanxi antiinflammatoryeffectofacombinationoffivecompoundsfromfivechineseherbalmedicinesusedinthetreatmentofcopd
AT guanqingzhou antiinflammatoryeffectofacombinationoffivecompoundsfromfivechineseherbalmedicinesusedinthetreatmentofcopd
AT meixiaofeng antiinflammatoryeffectofacombinationoffivecompoundsfromfivechineseherbalmedicinesusedinthetreatmentofcopd
AT qinyanqin antiinflammatoryeffectofacombinationoffivecompoundsfromfivechineseherbalmedicinesusedinthetreatmentofcopd